Literature DB >> 3323228

Examination of feces and serum for diagnosis of infant botulism in 336 patients.

C L Hatheway1, L M McCroskey.   

Abstract

In the 12-year period 1975 to 1987, feces from 336 infants were examined for botulinal neurotoxin and Clostridium botulinum. All the infants had illnesses which prompted their physicians to consider infant botulism in the diagnosis. Stool specimens from 113 of the infants yielded organisms that produced botulinal neurotoxins assumed to be responsible for the illness. The types of botulinal toxin in the confirmed cases were distributed as follows: 38 A, 69 B, 2 atypical B, 1 E, 1 F, 1 A + B, and 1 B + F. The type A and B toxins in a single infant were produced by two different strains of organism, and the type B and F toxins in another infant were produced by a single strain. The physiological characteristics of all the isolated toxigenic organisms except two were consistent with those of group I (proteolytic) C. botulinum. The toxigenic isolate from the infant with type E botulism was identified as C. butyricum, and that from the infant with type F botulism was identified as C. barati. Toxin of the same type as produced by the isolated organisms was identified in feces of 98 of 111 culture-positive infants. Botulinal toxin was identified in the serum of 9 of 67 culture-positive infants (8 of 22 infants with type A organisms; 1 of 43 infants with type B organisms; neither of 2 infants with A + B or atypical type B organisms). Botulinal toxin was not detected in feces (206 infants) or in serum (114 infants) of the culture-negative infants. The culture-positive infants had clinical features and a course of illness consistent with those of infant botulism. Most of the culture-negative infants probably had illnesses other than botulism, but specimens might have been obtained late in some infants' illnesses, when the organism had disappeared.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323228      PMCID: PMC269483          DOI: 10.1128/jcm.25.12.2334-2338.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Syndrome of botulism in infancy: clinical and electrophysiologic study.

Authors:  J Pickett; B Berg; E Chaplin; M A Brunstetter-Shafer
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

2.  Type F infant botulism.

Authors:  R E Hoffman; B J Pincomb; M R Skeels
Journal:  Am J Dis Child       Date:  1982-03

3.  Studies on strain 84 of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

4.  Infant botulism. Epidemiological, clinical, and laboratory aspects.

Authors:  S S Arnon; T F Midura; S A Clay; R M Wood; J Chin
Journal:  JAMA       Date:  1977-05-02       Impact factor: 56.272

5.  Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism.

Authors:  V R Dowell; L M McCroskey; C L Hatheway; G L Lombard; J M Hughes; M H Merson
Journal:  JAMA       Date:  1977-10-24       Impact factor: 56.272

6.  Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases.

Authors:  M Dezfulian; V R Dowell
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

7.  Isolation and enumeration of Clostridium botulinum by direct inoculation of infant fecal specimens on egg yolk agar and Clostridium botulinum isolation media.

Authors:  C Glasby; C L Hatheway
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

8.  Atypical toxin variant of Clostridium botulinum type B associated with infant botulism.

Authors:  C L Hatheway; L M McCroskey; G L Lombard; V R Dowell
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

9.  Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy.

Authors:  P Aureli; L Fenicia; B Pasolini; M Gianfranceschi; L M McCroskey; C L Hatheway
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

10.  Laboratory procedures for cases of suspected infant botulism.

Authors:  C L Hatheway
Journal:  Rev Infect Dis       Date:  1979 Jul-Aug
View more
  18 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 2.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Recovery of a strain of Clostridium botulinum producing both neurotoxin A and neurotoxin B from canned macrobiotic food.

Authors:  G Franciosa; L Fenicia; M Pourshaban; P Aureli
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

4.  First case of infant botulism caused by Clostridium baratii type F in California.

Authors:  Jason R Barash; Tania W H Tang; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.

Authors:  L S Siegel
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.

Authors:  D Akbulut; K A Grant; J McLauchlin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Pulsotype Diversity of Clostridium botulinum Strains Containing Serotypes A and/or B Genes.

Authors:  Jessica L Halpin; Lavin Joseph; Janet K Dykes; Loretta McCroskey; Elise Smith; Denise Toney; Steven Stroika; Kelley Hise; Susan Maslanka; Carolina Lúquez
Journal:  Foodborne Pathog Dis       Date:  2017-07-10       Impact factor: 3.171

8.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

9.  Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

Authors:  Theresa J Smith; Karen K Hill; Gary Xie; Brian T Foley; Charles H D Williamson; Jeffrey T Foster; Shannon L Johnson; Olga Chertkov; Hazuki Teshima; Henry S Gibbons; Lauren A Johnsky; Mark A Karavis; Leonard A Smith
Journal:  Infect Genet Evol       Date:  2014-12-06       Impact factor: 3.342

10.  Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism.

Authors:  Jason R Barash; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.